(Q34475730)

2 August 2017

1 reference

title

Proton pump inhibitors. Pharmacology and rationale for use in gastrointestinal disorders (English)

1 reference

2 August 2017

1 reference

Richardson P

1

1 reference

2 August 2017

Hawkey CJ

series ordinal

2

1 reference

2 August 2017

Stack WA

series ordinal

3

1 reference

2 August 2017

1 September 1998

1 reference

2 August 2017

1 reference

2 August 2017

56

1 reference

2 August 2017

3

1 reference

2 August 2017

307-335

1 reference

https://scigraph.springernature.com/pub.10.2165/00003495-199856030-00002

2 August 2017

0 references

cites work

A double-blind study of pantoprazole and omeprazole in the treatment of reflux oesophagitis: a multicentre trial

1 reference

12 December 2020

Partial regression of Barrett's esophagus by long-term therapy with high-dose omeprazole

1 reference

12 December 2020

1 reference

12 December 2020

Use of microbleeding and an ultrathin endoscope to assess gastric mucosal protection by famotidine

1 reference

12 December 2020

Pantoprazole versus omeprazole in the treatment of acute gastric ulcers.

1 reference

12 December 2020

Time-dependent changes in enterochromaffin-like cell kinetics in stomach of hypergastrinemic rats

1 reference

12 December 2020

Double-blind comparison of pantoprazole and omeprazole for the treatment of acute duodenal ulcer

1 reference

12 December 2020

1 reference

12 December 2020

Acute treatment of duodenal ulcer: experience with lansoprazole

1 reference

12 December 2020

Association between infection with Helicobacter pylori and risk of gastric cancer: evidence from a prospective investigation

1 reference

12 December 2020

How to treat Helicobacter pylori infection--should treatment strategies be based on testing bacterial susceptibility? A personal viewpoint

1 reference

12 December 2020

Abolition by omeprazole of aspirin induced gastric mucosal injury in man.

1 reference

12 December 2020

Omeprazole versus famotidine in the short-term treatment of duodenal ulcer disease.

1 reference

12 December 2020

Comparison of lansoprazole with omeprazole on 24-hour intragastric pH, acid secretion and serum gastrin in healthy volunteers.

1 reference

12 December 2020

Lansoprazole versus ranitidine in the maintenance treatment of reflux oesophagitis

1 reference

12 December 2020

Effective maintenance treatment of reflux esophagitis with low-dose lansoprazole. A randomized, double-blind, placebo-controlled trial

1 reference

12 December 2020

Lansoprazole for maintenance therapy of peptic ulcer disease: weekend full-dose or everyday half-dose administration?

1 reference

12 December 2020

Helicobacter pylori infection

1 reference

12 December 2020

Omeprazole versus placebo in duodenal ulcer healing. The United States experience

1 reference

12 December 2020

Treating the symptoms of gastro-oesophageal reflux disease: a double-blind comparison of omeprazole and cisapride.

1 reference

12 December 2020

Omeprazole enhances efficacy of triple therapy in eradicating Helicobacter pylori

1 reference

12 December 2020

Effect of omeprazole and sucralfate on prepyloric gastric ulcer. A double blind comparative trial and one year follow up.

1 reference

12 December 2020

A double-blind, randomized, parallel group study of omeprazole and ranitidine in Korean patients with gastric ulcer

1 reference

12 December 2020

Maintenance treatment for gastro-oesophageal reflux disease. A placebo-controlled evaluation of 10 milligrams omeprazole once daily in general practice

1 reference

12 December 2020

Double-blind multicentre comparison of omeprazole and ranitidine in the treatment of reflux oesophagitis

1 reference

12 December 2020

Effect of 10 mg and 20 mg omeprazole daily on duodenal ulcer: double-blind comparative trial

1 reference

12 December 2020

Omeprazole and ranitidine in duodenal ulcer healing and subsequent relapse: a randomized double-blind study with weekly endoscopic assessment.

1 reference

12 December 2020

A comparison of five maintenance therapies for reflux esophagitis

1 reference

12 December 2020

Prevention of duodenal ulcer relapse by long-term treatment with omeprazole

1 reference

12 December 2020

Potent inhibitory action of the gastric proton pump inhibitor lansoprazole against urease activity of Helicobacter pylori: unique action selective for H. pylori cells

1 reference

12 December 2020

Hyperplasia of histamine-depleted enterochromaffinlike cells in rat stomach using omeprazole and alpha-fluoromethylhistidine

1 reference

12 December 2020

Double blind cross-over placebo controlled study of omeprazole in the treatment of patients with reflux symptoms and physiological levels of acid reflux--the "sensitive oesophagus"

1 reference

12 December 2020

Omeprazole 10 milligrams once daily, omeprazole 20 milligrams once daily, or ranitidine 150 milligrams twice daily, evaluated as initial therapy for the relief of symptoms of gastro-oesophageal reflux disease in general practice

1 reference

12 December 2020

Omeprazole compared with misoprostol for ulcers associated with nonsteroidal antiinflammatory drugs. Omeprazole versus Misoprostol for NSAID-induced Ulcer Management (OMNIUM) Study Group.

1 reference

12 December 2020

Prevention of duodenal ulcer relapse with omeprazole 20 mg daily: a randomized double-blind, placebo-controlled study

1 reference

12 December 2020

A comparison of omeprazole with ranitidine for ulcers associated with nonsteroidal antiinflammatory drugs. Acid Suppression Trial: Ranitidine versus Omeprazole for NSAID-associated Ulcer Treatment (ASTRONAUT) Study Group

1 reference

12 December 2020

Pantoprazole and omeprazole in the treatment of reflux oesophagitis: a European multicentre study.

1 reference

12 December 2020

Campylobacter pyloridis-associated chronic active antral gastritis. A prospective study of its prevalence and the effects of antibacterial and antiulcer treatment

1 reference

12 December 2020

A comparison of omeprazole and placebo for bleeding peptic ulcer

1 reference

12 December 2020

Activity of lansoprazole against Helicobacter pylori

1 reference

12 December 2020

Helicobacter pylori infection and gastric carcinoma among Japanese Americans in Hawaii

1 reference

12 December 2020

Comparison of omeprazole and cimetidine in reflux oesophagitis: symptomatic, endoscopic, and histological evaluations

1 reference

12 December 2020

A trial of lansoprazole in refractory gastric ulcer

1 reference

12 December 2020

One-week omeprazole treatment in the diagnosis of gastro-oesophageal reflux disease

1 reference

12 December 2020

Comparison of once daily doses of lansoprazole (15, 30, and 60 mg) and placebo in patients with gastric ulcer.

1 reference

12 December 2020

Effect of omeprazole on the outcome of endoscopically treated bleeding peptic ulcers. Randomized double-blind placebo-controlled multicentre study

1 reference

12 December 2020

Effects of oral pantoprazole on 24-hour intragastric acidity and plasma gastrin profiles

1 reference

12 December 2020

Efficacy and tolerability of pantoprazole 40 mg versus 80 mg in patients with reflux oesophagitis

1 reference

12 December 2020

Zollinger-Ellison syndrome: pathogenesis, diagnosis, and management

1 reference

12 December 2020

Omeprazole in the treatment of patients with complicated gastro-oesophageal reflux disease

1 reference

12 December 2020

Inhibitory effects of intravenous lansoprazole on gastric acid hypersecretion in patients with postoperative stress.

1 reference

12 December 2020

Treatment of erosive reflux esophagitis resistant to H2-receptor antagonist therapy. Lansoprazole, a new proton pump inhibitor

1 reference

12 December 2020

Campylobacter pylori and peptic ulcer disease

1 reference

12 December 2020

Pathophysiological effects of long-term acid suppression in man.

1 reference

12 December 2020

U.S. experience with omeprazole in duodenal ulcer. Multicenter double-blind comparative study with ranitidine. The Omeprazole DU Comparative Study Group

1 reference

12 December 2020

Omeprazole v ranitidine for prevention of relapse in reflux oesophagitis. A controlled double blind trial of their efficacy and safety

1 reference

12 December 2020

Efficacy and safety of lansoprazole in the treatment of erosive reflux esophagitis. The Lansoprazole Group

1 reference

12 December 2020

Activity of omeprazole on Helicobacter pylori and relation to toxicity of strains

1 reference

12 December 2020

Comparison of pantoprazole versus omeprazole in the treatment of acute duodenal ulceration--a multicentre study

1 reference

12 December 2020

Six months of omeprazole 20 mg daily, 20 mg every other day or 40 mg at weekends in duodenal ulcer patients: a multicenter, prospective, comparative study. Interdisciplinary Group for Ulcer Study

1 reference

12 December 2020

Pantoprazole: a novel H+/K(+)-ATPase inhibitor with an improved pH stability

1 reference

12 December 2020

A prospective study of the effectiveness of low dose omeprazole as initial therapy in Zollinger-Ellison syndrome

1 reference

12 December 2020

Omeprazole. An update of its pharmacology and therapeutic use in acid-related disorders

1 reference

12 December 2020

Randomised, double blind comparison of omeprazole and cimetidine in the treatment of symptomatic gastric ulcer

1 reference

12 December 2020

Regression of columnar lined (Barrett's) oesophagus with continuous omeprazole therapy

1 reference

12 December 2020

Eradication of Helicobacter pylori using one-week triple therapies combining omeprazole with two antimicrobials: the MACH I Study

1 reference

12 December 2020

Continuous intravenous infusion of omeprazole in elderly patients with peptic ulcer bleeding. Results of a placebo-controlled multicenter study

1 reference

12 December 2020

Treatment of reflux esophagitis resistant to H2-receptor antagonists with lansoprazole, a new H+/K(+)-ATPase inhibitor: a controlled, double-blind study. Lansoprazole Study Group

1 reference

12 December 2020

Improved symptom relief and duodenal ulcer healing with lansoprazole, a new proton pump inhibitor, compared with ranitidine

1 reference

12 December 2020

Prevention of peptic ulcer and dyspeptic symptoms with omeprazole in patients receiving continuous non-steroidal anti-inflammatory drug therapy. A Nordic multicentre study

1 reference

12 December 2020

Famotidine for the prevention of gastric and duodenal ulcers caused by nonsteroidal antiinflammatory drugs

1 reference

12 December 2020

Omeprazole or ranitidine plus metoclopramide for patients with severe erosive oesophagitis. A cost-effectiveness analysis.

1 reference

12 December 2020

Sites of reaction of the gastric H,K-ATPase with extracytoplasmic thiol reagents.

1 reference

12 December 2020

Reflux symptom relief with omeprazole in patients without unequivocal oesophagitis

1 reference

12 December 2020

Effects of gastrin on the histamine-secretory and proliferative activity of cultured carcinoid cells derived from the stomach of the rodent Mastomys natalensis

1 reference

12 December 2020

Lansoprazole 30 mg versus omeprazole 40 mg in the treatment of reflux oesophagitis grade II, III and IVa (a Dutch multicentre trial). Dutch Study Group

1 reference

12 December 2020

A comparison of omeprazole and ranitidine for duodenal ulcer in South African patients. A multiracial study

1 reference

12 December 2020

Omeprazole as a risk factor for campylobacter gastroenteritis: case-control study

1 reference

12 December 2020

Oral phenytoin pharmacokinetics during omeprazole therapy

1 reference

12 December 2020

Omeprazole 20 mg uid and ranitidine 150 mg bid in the treatment of benign gastric ulcer. Italian Cooperative Group on Omeprazole

1 reference

12 December 2020

1 reference

12 December 2020

In vitro antibacterial activity of omeprazole and its selectivity for Helicobacter spp. are dependent on incubation conditions

1 reference

12 December 2020

Lansoprazole, a novel benzimidazole proton pump inhibitor, and its related compounds have selective activity against Helicobacter pylori

1 reference

12 December 2020

Omeprazole 20 mg and 40 mg daily in the treatment of gastric ulcer: a pilot study in Filipino patients.

1 reference

12 December 2020

Lansoprazole. An update of its pharmacological properties and clinical efficacy in the management of acid-related disorders

1 reference

12 December 2020

Pharmacokinetics of pantoprazole following single intravenous and oral administration to healthy male subjects

1 reference

12 December 2020

Comparison of lansoprazole and famotidine for gastric ulcer by endoscopic ultrasonography: a preliminary trial

1 reference

12 December 2020

[Healing of esophageal ulcer after treatment with omeprazole in a patient with scleroderma and Barrett's esophagus]

1 reference

12 December 2020

Long term continuous omeprazole treatment of patients with Barrett's oesophagus

1 reference

12 December 2020

Bacterial overgrowth during treatment with omeprazole compared with cimetidine: a prospective randomised double blind study

1 reference

12 December 2020

Evaluation of gastric ulcer healing by lansoprazole by measurement of ulcer diameter

1 reference

12 December 2020

Omeprazole (40 mg) is superior to ranitidine in short-term treatment of ulcerative reflux esophagitis

1 reference

12 December 2020

Effects of hypochlorhydria and hypergastrinemia on structure and function of gastrointestinal cells. A review and analysis

1 reference

12 December 2020

Omeprazole provides quicker symptom relief and duodenal ulcer healing than ranitidine.

1 reference

12 December 2020

Omeprazole and H2-receptor antagonists in the acute treatment of duodenal ulcer, gastric ulcer and reflux oesophagitis: a meta-analysis.

1 reference

12 December 2020

Gastrin receptors in human gastric scirrhous carcinoma

1 reference

12 December 2020

Risk factors for gastrointestinal bleeding in critically ill patients. Canadian Critical Care Trials Group

1 reference

12 December 2020

Gastro-oesophageal reflux disease in primary care: an international study of different treatment strategies with omeprazole. International GORD Study Group

1 reference

12 December 2020

Effect of omeprazole and cimetidine on duodenal ulcer. A double-blind comparative trial

1 reference

12 December 2020

[Stress bleeding. 1. Pathogenesis, clinical picture and therapy]

1 reference

12 December 2020

One week triple therapy for Helicobacter pylori: a multicentre comparative study. Lansoprazole Helicobacter Study Group

1 reference

12 December 2020

Consensus conference: Therapeutic endoscopy and bleeding ulcers

1 reference

12 December 2020

Efficacy of lansoprazole against peptic ulcers induced by non-steroidal anti-inflammatory drugs: endoscopic evaluation of ulcer healing

1 reference

12 December 2020

Comparison of once-daily doses of omeprazole (40 and 20 mg) and placebo in the treatment of benign gastric ulcer: a multicenter, randomized, double-blind study

1 reference

12 December 2020

A study of the interaction between omeprazole and phenytoin in epileptic patients

1 reference

12 December 2020

Omeprazole, nitrendipine, famotidine and stress-induced ulcers

1 reference

12 December 2020

Comparison of pantoprazole and ranitidine in the treatment of acute duodenal ulcer. Pantoprazole-Duodenal Ulcer-Study Group.

1 reference

12 December 2020

Choosing the best anti-Helicobacter pylori therapy: effect of antimicrobial resistance.

1 reference

12 December 2020

Comparison of omeprazole and ranitidine for stress ulcer prophylaxis.

1 reference

12 December 2020

Structural aspects of the gastric H,K ATPase

1 reference

12 December 2020

Non-steroidal anti-inflammatory drugs and peptic ulcers

1 reference

12 December 2020

Prospective evaluation of omeprazole treatment in reflux oesophagitis refractory to H2-receptor antagonists.

1 reference

12 December 2020

Omeprazole vs. ranitidine in the short-term treatment of duodenal ulcer: an Italian multicenter study.

1 reference

12 December 2020

Heartburn without oesophagitis: efficacy of omeprazole therapy and features determining therapeutic response

1 reference

12 December 2020

Treatment of duodenal ulcer with omeprazole or ranitidine in a Brazilian population: a multicenter double-blind, parallel group study

1 reference

12 December 2020

Twenty-four-hour monitoring of intragastric acidity: comparison between lansoprazole 30mg and pantoprazole 40mg

1 reference

12 December 2020

Prevention of relapse of reflux oesophagitis after endoscopic healing: the efficacy and safety of omeprazole compared with ranitidine

1 reference

12 December 2020

Human gastric acid secretion following repeated doses of AG-1749.

1 reference

12 December 2020

[Omeprazole (20 mg daily) compared to ranitidine (150 mg twice daily) in the treatment of esophagitis caused by reflux. Results of a double-blind randomized multicenter trial in France and Belgium]

1 reference

12 December 2020

Long-term sequelae of Helicobacter pylori gastritis.

1 reference

12 December 2020

Current guidelines on stress ulcer prophylaxis

1 reference

12 December 2020

Dose-range finding study with the proton pump inhibitor pantoprazole in acute duodenal ulcer patients

1 reference

12 December 2020

Lansoprazole versus omeprazole in active duodenal ulcer. A double-blind, randomized, comparative study

1 reference

12 December 2020

Lansoprazole versus ranitidine for the treatment of reflux oesophagitis. UK Lansoprazole Clinical Research Group

1 reference

12 December 2020

Omeprazole in the long-term treatment of gastro-oesophageal reflux disease. A double-blind randomized dose-finding study

1 reference

12 December 2020

Highly effective twice-daily triple therapies for Helicobacter pylori infection and peptic ulcer disease: does in vitro metronidazole resistance have any clinical relevance?

1 reference

12 December 2020

Proton pump inhibitors or histamine-2 receptor antagonists for the prevention of recurrences of erosive reflux esophagitis: a cost-effectiveness analysis.

1 reference

12 December 2020

Omeprazole or high-dose ranitidine in the treatment of patients with reflux oesophagitis not responding to 'standard doses' of H2-receptor antagonists.

1 reference

12 December 2020

Stress ulcer prophylaxis in medical patients: who, what, and how much?

1 reference

12 December 2020

Long-term treatment with lansoprazole for patients with Zollinger-Ellison syndrome

1 reference

12 December 2020

Omeprazole or ranitidine in the treatment of reflux esophagitis. Results of a double-blind, randomized, Scandinavian multicenter study

1 reference

12 December 2020

Long term treatment with omeprazole 20 mg three days a week or 10 mg daily in the prevention of duodenal ulcer relapse.

1 reference

12 December 2020

Duodenal ulcer: the villain unmasked?

1 reference

12 December 2020

Helicobacter pylori urease inhibition by rabeprazole, a proton pump inhibitor

1 reference

12 December 2020

Long-term treatment with lansoprazole of patients with duodenal ulcer and basal acid output of more than 15 mmol/h

1 reference

12 December 2020

Candida overgrowth after treatment of duodenal ulcer. A comparison of cimetidine, famotidine, and omeprazole

1 reference

12 December 2020

Comparative trial of pantoprazole and ranitidine in the treatment of reflux esophagitis. Results of a German multicenter study

1 reference

12 December 2020

20 versus 30 mg omeprazole once daily: effect on healing rates in 115 duodenal ulcer patients

1 reference

12 December 2020

Treatment and prevention of relapse of mild oesophagitis with omeprazole and cisapride: comparison of two strategies

1 reference

12 December 2020

Double-blind comparison of lansoprazole, ranitidine, and placebo in the treatment of acute duodenal ulcer. Lansoprazole Study Group

1 reference

12 December 2020

Rapid symptom relief in reflux oesophagitis: a comparison of lansoprazole and omeprazole

1 reference

12 December 2020

Omeprazole in acute and long-term treatment of Asian patients with peptic ulcer refractory to H2-antagonists.

1 reference

12 December 2020

Antibacterial activity of pantoprazole and omeprazole againstHelicobacter pylori

1 reference

12 December 2020

Effect of up to 3 years of high-dose lansoprazole on Barrett's esophagus.

1 reference

12 December 2020

Is omeprazole helpful in inflammatory bowel disease?

1 reference

12 December 2020

The pharmacology of the gastric acid pump: the H+,K+ ATPase

1 reference

12 December 2020

The chemotherapeutic effects of H+/K+ inhibitors on Helicobacter pylori infection

1 reference

12 December 2020

Primary gastroduodenal prophylaxis with omeprazole for non-steroidal anti-inflammatory drug users

1 reference

12 December 2020

Effect of omeprazole and ranitidine on ulcer healing and relapse rates in patients with benign gastric ulcer

1 reference

12 December 2020

Omeprazole in the management of refractory duodenal ulcer

1 reference

12 December 2020

Pantoprazole is superior to ranitidine in the treatment of acute gastric ulcer

1 reference

12 December 2020

The effect of environmental pH on the proton motive force of Helicobacter pylori

1 reference

12 December 2020

Effect of omeprazole on the distribution of metronidazole, amoxicillin, and clarithromycin in human gastric juice

1 reference

12 December 2020

Pharmacokinetic properties of E3810, a new proton pump inhibitor, in healthy male volunteers.

1 reference

12 December 2020

Changes in the intragastric distribution of Helicobacter pylori during treatment with omeprazole

1 reference

12 December 2020

Pantoprazole and ranitidine in the treatment of acute duodenal ulcer. A multicentre study

1 reference

12 December 2020

Altered bowel function and duodenal bacterial overgrowth in patients treated with omeprazole

1 reference

12 December 2020

Interleukin-8 expression in Helicobacter pylori infected, normal, and neoplastic gastroduodenal mucosa

1 reference

12 December 2020

Omeprazole 10 mg or 20 mg once daily in the prevention of recurrence of reflux oesophagitis. Solo Investigator Group

1 reference

12 December 2020

Omeprazole or ranitidine in long-term treatment of reflux esophagitis. The Scandinavian Clinics for United Research Group

1 reference

12 December 2020

Normalization of esophageal pH with high-dose proton pump inhibitor therapy does not result in regression of Barrett's esophagus

1 reference

12 December 2020

Pharmacokinetics and metabolism of omeprazole in animals and man--an overview

1 reference

12 December 2020

Pantoprazole-based dual and triple therapy for the eradication of Helicobacter pylori infection: a randomized controlled trial

1 reference

12 December 2020

Inhibitions of acid secretion by E3810 and omeprazole, and their reversal by glutathione.

1 reference

12 December 2020

The effect of omeprazole and ranitidine on ulcer healing, relief of symptoms, and incidence of adverse events in the treatment of duodenal ulcer patients

1 reference

12 December 2020

Treatment of refractory peptic ulcer with omeprazole or continued H2 receptor antagonists: a controlled clinical trial

1 reference

12 December 2020

Eradication of Helicobacter pylori: an objective assessment of current therapies

1 reference

12 December 2020

Safety experience from long-term treatment with omeprazole

1 reference

12 December 2020

A comparison of three doses of lansoprazole (15, 30 and 60 mg) and placebo in the treatment of duodenal ulcer. The Lansoprazole Study Group

1 reference

12 December 2020

Eradication of Helicobacter pylori with clarithromycin and omeprazole

1 reference

12 December 2020

A study of the interaction of omeprazole and warfarin in anticoagulated patients

1 reference

12 December 2020

Omeprazole versus placebo for acute upper gastrointestinal bleeding: randomised double blind controlled trial

1 reference

12 December 2020

Comparison of the cost-efficacy ratio of omeprazole and ranitidine in the treatment of reflux esophagitis

1 reference

12 December 2020

Short report: treatment of gastric ulcer with lansoprazole or ranitidine: a multicentre clinical trial

1 reference

12 December 2020

Inhibitory action of lansoprazole and its analogs against Helicobacter pylori: inhibition of growth is not related to inhibition of urease

1 reference

12 December 2020

Stereoselective interaction of omeprazole with warfarin in healthy men

1 reference

12 December 2020

Effect of omeprazole and cimetidine on plasma diazepam levels.

1 reference

12 December 2020

Does 40 mg omeprazole daily offer additional benefit over 20 mg daily in patients requiring more than 4 weeks of treatment for symptomatic reflux oesophagitis?

1 reference

12 December 2020

Detection of the intragastric sites at which Helicobacter pylori evades treatment with amoxycillin and cimetidine

1 reference

12 December 2020

Long-term maintenance treatment of reflux esophagitis with omeprazole. Prospective study in patients with H2-blocker-resistant esophagitis

1 reference

12 December 2020

Symptom relief and duodenal ulcer healing with omeprazole or cimetidine. Opus (Omeprazole Peptic Ulcer Study) Research Group

1 reference

12 December 2020

Omeprazole (20 mg daily) versus cimetidine (1200 mg daily) in duodenal ulcer healing and pain relief

1 reference

12 December 2020

Atrophic gastritis and Helicobacter pylori infection in patients with reflux esophagitis treated with omeprazole or fundoplication

1 reference

12 December 2020

Dose-response study of omeprazole on meal-stimulated gastric acid secretion and gastrin release

1 reference

12 December 2020

Meta-analysis of randomized clinical trials comparing lansoprazole with ranitidine or famotidine in the treatment of acute duodenal ulcer.

1 reference

12 December 2020

Pantoprazole. A review of its pharmacological properties and therapeutic use in acid-related disorders

1 reference

12 December 2020

Helicobacter pylori does not migrate from the antrum to the corpus in response to omeprazole

1 reference

12 December 2020

H2-receptor antagonist-refractory ulcer: its pathophysiology and treatment

1 reference

12 December 2020

Low dose clarithromycin plus omeprazole eradicates Helicobacter pylori in duodenal ulcer disease

1 reference

12 December 2020

Prevention of duodenal ulcer recurrence with 15 mg lansoprazole: a double-blind placebo-controlled study. The Lansoprazole Study Group.

1 reference

12 December 2020

Effects of single and repeated doses of omeprazole on gastric acid and pepsin secretion in man

1 reference

12 December 2020

Triple therapy as a cure for Helicobacter pylori infection

1 reference

12 December 2020

Effect of omeprazole and cimetidine on prepyloric gastric ulcer: double blind comparative trial

1 reference

12 December 2020

Helicobacter pylori infection and the risk of gastric carcinoma

1 reference

12 December 2020

NIH Consensus Conference. Helicobacter pylori in peptic ulcer disease. NIH Consensus Development Panel on Helicobacter pylori in Peptic Ulcer Disease

1 reference

12 December 2020

Helicobacter pylori infection and gastric lymphoma

1 reference

12 December 2020

Prevention of Relapse of Reflux Esophagitis after Endoscopic Healing: The Efficacy and Safety of Omeprazole Compared with Ranitidine

1 reference

12 December 2020

Randomised trial of eradication of Helicobacter pylori before non-steroidal anti-inflammatory drug therapy to prevent peptic ulcers

1 reference

12 December 2020

The effect of food and antacids on lansoprazole absorption and disposition

1 reference

12 December 2020

Pathophysiology of gastroesophageal reflux. Lower esophageal sphincter dysfunction in gastroesophageal reflux disease

1 reference

12 December 2020

Partial gastric corpectomy results in hypergastrinemia and development of gastric enterochromaffinlike-cell carcinoids in the rat.

1 reference

12 December 2020

10.2165/00003495-199856030-00002

Identifiers

DOI

1 reference

Dimensions Publication ID

2 August 2017

0 references

1 reference